Literature DB >> 25795317

Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.

S Vourli1, F Frantzeskaki2, J Meletiadis3, L Stournara2, A Armaganidis2, L Zerva3, G Dimopoulos2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25795317     DOI: 10.1016/j.ijantimicag.2015.02.005

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  6 in total

Review 1.  In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.

Authors:  Stamatis Karakonstantis; Petros Ioannou; Diamantis D Kofteridis
Journal:  Infection       Date:  2022-01-04       Impact factor: 3.553

Review 2.  Antibacterial pyrazoles: tackling resistant bacteria.

Authors:  Mohammad A Alam
Journal:  Future Med Chem       Date:  2022-01-20       Impact factor: 3.808

3.  Clinical response and outcome of pneumonia due to multi-drug resistant Acinetobacter baumannii in critically ill patients.

Authors:  Lida Shojaei; Mostafa Mohammadi; Mohammad-Taghi Beigmohammadi; Mahsa Doomanlou; Alireza Abdollahi; Mohammad Mehdi Feizabadi; Hossein Khalili
Journal:  Iran J Microbiol       Date:  2016-10

Review 4.  Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features.

Authors:  Saad B Almasaudi
Journal:  Saudi J Biol Sci       Date:  2016-02-11       Impact factor: 4.219

5.  Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis.

Authors:  Zhihui Jiang; Xianxia He; Jian Li
Journal:  Infect Drug Resist       Date:  2018-08-07       Impact factor: 4.003

6.  In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran.

Authors:  Raziyeh Kheshti; Bahman Pourabbas; Maryam Mosayebi; Afsaneh Vazin
Journal:  Infect Drug Resist       Date:  2018-12-31       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.